[1]CHOW LQM.Head and neck cancer[J].New England Journal of Medicine,2020,382(1):60-72.
[2]LIN TY,CHAN HH,CHEN SH,et al.BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells[J].Autophagy,2020,16(7):1296-1313.
[3]NEW J,THOMAS SM.Autophagy-dependent secretion:mechanism,factors secreted,and disease implications[J].Autophagy,2019,15(10):1682-1693.
[4]LI YU,YANG CHEN,SHARON A,et al.Autophagy pathway:Cellular and molecular mechanisms[J].Autophagy,2018,14(2):207-215.
[5]YOOMI,CHUN,JOUNGMOK,et al.Autophagy:An essential degradation program for cellular homeostasis and life[J/OL].Cells,(2018-12-19)[2020-07-04].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315530/.DOI: 10.3390/cells7120278.
[6]YORIMITSU T,KLIONSKY DJ.Autophagy:molecular machinery for self-eating [J].Cell Death Differ,2005,12(Suppl 2):1542-1552.
[7]WIRAWAN E,VANDEN BERGHE T,LIPPENS S,et al.Autophagy:for better or for worse [J].Cell Res,2012,22(1):43-61.
[8]FALZONE L,SALOMONE S,LIBRA M.Evolution of cancer pharmacological treatments at the turn of the third millennium [J].Front Pharmacol,2018,9 :1300.
[9]KENTA M,BEATRICE G,JILL W,et al.A tale of two approaches:complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments [J].Carcinogenesis,2013,34(4):725-738.
[10]MARTA PREZ-HERNNDEZ,ARIAS A,DAVID MARTNEZ-GARCA,et al.Targeting autophagy for cancer treatment and tumor chemosensitization[J].Cancers,2019,11(10):1599.
[11]LEVY JMM,TOWERS CG,THORBURN A.Targeting autophagy in cancer[J].Nat Rev Cancer,2017,17(9):528-542.
[12]LI X,ZHOU Y,LI Y,et al.Autophagy:A novel mechanism of chemoresistance in cancers[J/OL].Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,(2019-11-01)[2020-07-06].https://doi.org/10.1016/j.biopha.2019.109415.
[13]YANG Z,KLIONSKY DJ.Mammalian autophagy:core molecular machinery and signaling regulation [J].Curr Opin Cell Biol,2009,22(2):124-131.
[14]FAN Z,HUANGFU X,LIU Z.Effect of autophagy on cisplatin-induced bladder cancer cell apoptosis.[ J].Panminerva Med,2017,59(1):1-8.
[15]FREDDIE,BRAY,JACQUES,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:a Cancer Journal for Clinicians,2018,68(6):394-424.
[16]LEE JG,SHIN JH,SHIM HS,et al.Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions[J].Respiratory Research,2015,16:138.
[17]DATTA S,CHOUDHURY D,DAS A,et al.Autophagy inhibition with chloroquine reverts paclitaxel resistance and attenuates metastatic potential in human nonsmall lung adenocarcinoma A549 cells via ROS mediated modulation of β-catenin pathway [J].Apoptosis An International Journal on Programmed Cell Death,2019,24(5-6):414-433.
[18]SHI S,TAN P,YAN B,et al.ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells[J].Oncology Reports,2016,35(5):2606-2614.
[19]WU HM,SHAO LJ,JIANG ZF,et al.Gemcitabine-induced autophagy protects human lung cancer cells from apoptotic death [J].Lung,2016,194(6):1-8.
[20]ENDO S,UCHIBORI M,SUYAMA M,et al.Novel Atg4B inhibitors potentiate cisplatin therapy in lung cancer cells through blockade of autophagy [J/OL].Computational Toxicology,(2019-11-01)[2020-07-06].https://doi.org/10.1016/j.comtox.2019.100095.
[21]WANG H,CHEN J,ZHANG S,et al.miR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer [J/OL].Cancer Cell Int,(2020-06-19)[2020-07-08].https://doi.org/10.1186/s12935-020-01284-x.
[22]ZHAO L,WU X,ZANG Z,et al.ELF1 suppresses autophagy to reduce cisplatin resistance via the miR-152-3p/NCAM1/ERK axis in lung cancer cells[J].Cancer Sci,2023,114(6):2650-2663.
[23]PAN ST,ZHOU J,YANG F,et al.Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells [J/OL].BMC Cancer,(2020-07-08)[2020-07-12].https://doi.org/10.1186/s12885-020-07111-w.
[24]WEIN L,LOI S.Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer(TNBC)[J].The Breast,2017,34(Suppl 1):S27-S30.
[25]DAS CK,LINDER B,BONN F,et al.BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells[J].Neoplasia,2018,20(3):263-279.
[26]LIU Z,SHI A,SONG D,et al.Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction[J].American Journal of Cancer Research,2017,7(3):574-583.
[27]ZHANG LH,YANG AJ,WANG M,et al.Enhanced autophagy reveals vulnerability of P-gp mediated epirubicin resistance in triple negative breast cancer cells[J].Apoptosis,2016,21(4):473-488.
[28]LIN HY,KUEI CH,LEE HH,et al.TNFSF13 upregulation confers chemotherapeutic resistance via triggering autophagy initiation in triple-negative breast cancer[J].Journal of Molecular Medicine,2020,98(9):1255-1267.
[29]ZHANG P,LIU X,LI H,et al.TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway[J/OL].Sci Rep,(2017-06-09)[2020-07-10].https://doi.org/10.1038/s41598-017-03230-w.
[30]LIU B,QI X,ZHANG X,et al.Med19 is involved in chemoresistance by mediating autophagy through HMGB1 in breast cancer[J].Journal of Cellular Biochemistry,2019,120(1):507-518.
[31]DING LY,CHU M,JIAO YS,et al.TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231[J/OL].PLoS One,(2018-09-20)[2020-07-08].https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0203833.DOI:10.1371/journal.pone.0203833.
[32]TANG ZN,BI XF,CHEN WL,et al.RANKL promotes chemotherapy resistance in breast cancer cells through STAT3 mediated autophagy induction[J].Clin Breast Cancer,2023,23:388-396.
[33]PEDRO J,TRRAGA LPEZ,JUAN SOLERA,et al.Primary and secondary prevention of colorectal cancer [J/OL].Clin Med Insights Gastroenterol,(2014-07-14)[2020-07-07].https://journals.sagepub.com/doi/full/10.4137/CGast.S14039.
[34]ANDR T,GRAMONT AD.An overview of adjuvant systemic chemotherapy for colon cancer [J].Clinical Colorectal Cancer,2004,4(supp-S1):S22-S28.
[35]SASAKI K,TSUNO NH,SUNAMI E,et al.Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells [J].Bmc Cancer,2010,10(1):370.
[36]RAMIREZ JAZ,ROMAGNOLI GG,FALASCO BF,et al.Blocking drug-induced autophagy with chloroquine in HCT-116 colon cancer cells enhances DC maturation and T cell responses induced by tumor cell lysate [J/OL].International Immunopharmacology,(2020-04-13)[2020-07-10].https://www.sciencedirect.com/science/article/pii/S1567576920306354.
[37]LI J,HOU N,FARIED A,et al.Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model[J].European Journal of Cancer,2010,46(10):1900-1909.
[38]LI J,HOU N,FARIED A,et al.Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells[J].Annals of Surgical Oncology,2009,16(3):761-771.
[39]TAN S,SHI H,BA M,et al.miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy[J].International Journal of Molecular Medicine,2016,37(4):1030-1038.
[40]ZHANG P,LAI ZL,CHEN HF,et al.Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy,AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice[J/OL].Journal of Experimental & Clinical Cancer Research,(2017-12-22)[2020-07-10].https://link.springer.com/article/10.1186/s13046-017-0661-7.DOI:10.1186/s13046-017-0661-7.
[41]CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015 [J].CA Cancer J Clin,2016,66(2):115-132.
[42]JASON,M,FARROW,et al.Autophagy as a modulator and target in prostate cancer[J].Nature Reviews Urology,2014,11(9):508-516.
[43]JIANG,PEIDU,MIZUSHIMA,et al.LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells[J].Methods,2015,75:13-18.
[44]LORENTE J,VELANDIA C,LEAL JA,et al.The interplay between autophagy and tumorigenesis:exploiting autophagy as a means of anticancer therapy[J].Biological Reviews of the Cambridge Philosophical Society,2018,93(1):152-165.
[45]WANG Q,HE WY,ZENG YZ,et al.Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells[J].International Urology & Nephrology,2018,50(4):675-686.
[46]PICKARD RD,SPENCER BH,MCFARLAND AJ,et al.Paradoxical effects of the autophagy inhibitor 3-methyladenine on docetaxel-induced toxicity in PC-3 and LNCaP prostate cancer cells[J].Naunyn-Schmiedeberg's Archives of Pharmacology,2015,388(7):793-799.
[47]ZHANG Y,YUAN Y,ZHANG X,et al.HMGB1-mediated autophagy confers resistance to gemcitabine in hormone-independent prostate cancer cells[J].Oncology Letters,2017,14(5):6285-6290.
[48]HU F,ZHAO Y,YU Y,et al.Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3 [J].Cancer Letters,2018,416:24-30.
[49]JIA J,ZHANG HB,SHI Q,et al.KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy[J].Theranostics,2019,9(19):5464-5477.
[50]ZENG J,LIU W,FAN YZ,et al.PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy[J].Theranostics,2018,8(1):109-123.
[51]LIN JZ,WANG WW,HU TT,et al.FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy[J].Cancer Letters,2020,469:481-489.
[52]RICCARDO C,MARINA MM,ELENA CM,et al.Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells[J/OL].Cell Death & Disease,(2018-08-30)[2020-07-11].https://doi.org/10.1038/s41419-018-0866-5.
[53]O' NEILL AJ,PRENCIPE M,DOWLING C,et al.Characterisation and manipulation of docetaxel resistant prostate cancer cell lines[J].Molecular Cancer,2011,10:126.
[54]HANSEN AR,TANNOCK IF,TEMPLETON A,et al.Pantoprazole affecting docetaxel resistance pathways via autophagy(pandora):phase II trial of high dose pantoprazole(autophagy inhibitor) with docetaxel in metastatic castration-resistant prostate cancer(mCRPC)[J].The Oncologist,2019,24(9):1188-1194.
[55]FERNNDEZ MARIO I,MAURIZIO B,CLARK PE,et al.Epidemiology,prevention,screening,diagnosis,and evaluation:update of the ICUD-SIU joint consultation on bladder cancer[J].World Journal of Urology,2019,37(1):3-13.
[56]HUANG X,ZHANG H,YANG X,et al.Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells[J].Anticancer Drugs,2017,28(6):596-602.
[57]LI K,CHEN X,LIU C,et al.Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells[J].Biochem Biophys Res Commun,2015,460(2):380-385.
[58]LIN J,LIN Y,TSAI T,et al.Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells[J].Drug Des Devel Ther,2017,11(8):1517-1533.
[59]YIN L,LIU S,LI C,et al.CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer:the effect is autophagy-associated[J].Tumor Biol,2016,37(9):12731-12742.
[60]WANG YC,TANG Z,ZHANG C,et al.miR-7-5p suppresses invasion via downregulation of the autophagy-related gene ATG7 and increases chemoresistance to cisplatin in BCa[J].Bioengineered,2022,13(3):7328-7339.